Epitalon
Protects the caps on your DNA.
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian researcher Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It was designed as a synthetic analog of Epithalamin, a pineal-gland extract Khavinson's team studied for decades. Most published research is Russian and has not been widely replicated in Western trials — but the aging and telomere-related findings are why longevity biohackers pay attention.
In vitro, Epitalon has been shown to activate telomerase, the enzyme that maintains telomere length. This could allow cells to divide more times before senescing. Also increases nocturnal melatonin production, which may drive many of the sleep and circadian-rhythm benefits users report.
- E.01In vitro studies show telomerase activation and telomere elongation in human somatic cells.
- E.02Long-running Russian cohort studies suggest reduced mortality and lower age-related disease in elderly populations.
- E.03Improved melatonin regulation and sleep architecture reported in clinical work.
- E.04Evidence base is largely from a single Russian research group — Western replication is limited.
Excellent tolerability across decades of Russian use. No significant adverse events reported in the literature. Contraindicated for active cancer given the telomerase-activating mechanism.
Often cycled seasonally with GH peptides (CJC/Ipamorelin) or GHK-Cu for a broader longevity protocol.
Research use only in the US. Registered as a geroprotector in Russia.
How does Epitalon work?+
What are the reported benefits of Epitalon?+
Is Epitalon safe?+
What is the regulatory status of Epitalon?+
This page summarizes publicly available research. Nothing here is medical advice, a prescription, or a diagnosis. Peptides described are not FDA-approved for the uses discussed unless explicitly noted. Consult a qualified physician before starting any protocol.